Tirdzniecība Eagle Pharm - EGRX CFD
Pievienot izlasei- Kopsavilkums
- Vēsturiskie Dati
- Notikumi
- Peļņas Atskaite
- Bilance
- Naudas Plūsma
- Īpašums
Tirdzniecības Nosacījumi
| Starpība | - | ||||||||
|
Garās pozīcijas nodeva naktij
Long position overnight fee
Doties uz platformu | -0.024068% | ||||||||
|
Īsās pozīcijas nodeva naktij
Short position overnight fee
Doties uz platformu | 0.001846% | ||||||||
| Nakts laika nodeva | 21:00 (UTC) | ||||||||
| Min. tirgotais daudzums | 1 | ||||||||
| Valūta | USD | ||||||||
| Drošības rezerve | 20% | ||||||||
| Fondu birža | United States of America | ||||||||
| Tirdzniecības komisija | 0% |
*Information provided by Capital.com
Galvenie Statistikas Dati
| Iepriekš. aizvērt* | N/A |
| Atvērt* | N/A |
| Izmaiņas par 1 gadu* | N/A |
| Dienas Diapazons* | N/A |
| 52 ned Diapazons | 23.87-51.60 |
| Vidējais apjoms (10 dienas) | 302.08K |
| Vidējais apjoms (3 mēneši) | 3.41M |
| Tirgus Kapitalizācija | 368.58M |
| Cenas/Peļņas Attiecība | 10.21 |
| Izvietotās Akcijas | 13.08M |
| Ieņēmumi | 316.61M |
| EPS | 2.76 |
| Dividende (Ienesīgums %) | N/A |
| Beta | 0.91 |
| Nākamās Peļņas Datums | May 8, 2023 |
"Visus datus nodrošina Refinitiv, izņemot datus, kas atzīmēti ar zvaigznīti, kas ir *dati, kurus nodrošina Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Aizvēršana | Change | Change (%) | Atvēršana | High | Low |
|---|
Eagle Pharm Events
| Laiks (UTC) (UTC) | Valsts | Notikums |
|---|---|---|
| No events scheduled | ||
- Ikgadējs
- Ceturkšņa
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Kopējie ienākumi | 316.61 | 171.546 | 187.802 | 195.892 | 213.312 |
| Ienākumi | 316.61 | 171.546 | 187.802 | 195.892 | 213.312 |
| Cost of Revenue, Total | 94.936 | 42.18 | 45.465 | 60.897 | 61.916 |
| Bruto Peļņa | 221.674 | 129.366 | 142.337 | 134.995 | 151.396 |
| Kopējie Darbības Izdevumi | 235.65 | 168.777 | 154.848 | 174.077 | 176.696 |
| Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 106.626 | 75.322 | 78.598 | 76.37 | 60.509 |
| Pētniecība un Attīstība | 34.088 | 51.275 | 30.785 | 36.81 | 44.419 |
| Neparedzēti Izdevumi (Ienākumi) | 0 | 0 | 10.615 | ||
| Darbības Izdevumi | 80.96 | 2.769 | 32.954 | 21.815 | 36.616 |
| Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -3.774 | -7.275 | -2.015 | -0.517 | -2.578 |
| Citi, Neto | -15.753 | -0.042 | -8.262 | 0.7 | |
| Neto Ienākumi Pirms Nodokļu Nomaksas | 61.433 | -4.548 | 22.677 | 21.998 | 34.038 |
| Neto Ienākumi Pēc Nodokļu Nomaksas | 35.642 | -8.627 | 11.989 | 14.313 | 31.903 |
| Neto Ienākumi Pirms Ārkārtas Posteņiem | 35.642 | -8.627 | 11.989 | 14.313 | 31.903 |
| Neto Ienākumi | 35.642 | -8.627 | 11.989 | 14.313 | 31.903 |
| Total Adjustments to Net Income | |||||
| Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | 35.642 | -8.627 | 11.989 | 14.313 | 31.903 |
| Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | 35.642 | -8.627 | 11.989 | 14.313 | 31.903 |
| Atšķaidītie Neto Ienākumi | 35.642 | -8.627 | 11.989 | 14.313 | 31.903 |
| Atšķaidītie Ienākumi par Akcijām | 13.0655 | 13.0511 | 13.7714 | 14.1387 | 15.2787 |
| Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | 2.72795 | -0.66102 | 0.87057 | 1.01233 | 2.08808 |
| Atšķaidītā Normalizētā Peļņa par Akciju | 3.11654 | -0.66102 | 0.87057 | 1.01233 | 2.73926 |
| Other Operating Expenses, Total | 0 | 0 | -0.763 | ||
| Ārkārtas Posteņi Kopā |
| Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
|---|---|---|---|---|---|
| Kopējie ienākumi | 60.699 | 65.901 | 74.136 | 115.874 | 42.32 |
| Ienākumi | 60.699 | 65.901 | 74.136 | 115.874 | 42.32 |
| Cost of Revenue, Total | 19.866 | 23.651 | 23.664 | 27.755 | 12.309 |
| Bruto Peļņa | 40.833 | 42.25 | 50.472 | 88.119 | 30.011 |
| Kopējie Darbības Izdevumi | 51.233 | 56.439 | 71.933 | 56.045 | 36.421 |
| Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 24.15 | 23.462 | 36.832 | 22.182 | 20.325 |
| Pētniecība un Attīstība | 7.217 | 9.326 | 11.437 | 6.108 | 3.787 |
| Darbības Izdevumi | 9.466 | 9.462 | 2.203 | 59.829 | 5.899 |
| Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -1.663 | -1.591 | -1.008 | -2.712 | -4.53 |
| Citi, Neto | 5.501 | -11.534 | -7.063 | 0.543 | -0.145 |
| Neto Ienākumi Pirms Nodokļu Nomaksas | 13.304 | -3.663 | -5.868 | 57.66 | 1.224 |
| Neto Ienākumi Pēc Nodokļu Nomaksas | 8.165 | -7.131 | -9.45 | 44.058 | -6.196 |
| Neto Ienākumi Pirms Ārkārtas Posteņiem | 8.165 | -7.131 | -9.45 | 44.058 | -6.196 |
| Neto Ienākumi | 8.165 | -7.131 | -9.45 | 44.058 | -6.196 |
| Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | 8.165 | -7.131 | -9.45 | 44.058 | -6.196 |
| Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | 8.165 | -7.131 | -9.45 | 44.058 | -6.196 |
| Atšķaidītie Neto Ienākumi | 8.165 | -7.131 | -9.45 | 44.058 | -6.196 |
| Atšķaidītie Ienākumi par Akcijām | 13.1694 | 13.1669 | 12.8361 | 12.9068 | 12.8948 |
| Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | 0.62 | -0.54158 | -0.7362 | 3.41355 | -0.4805 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
| Atšķaidītā Normalizētā Peļņa par Akciju | 0.6234 | -0.54158 | -0.7362 | 3.41355 | -0.4805 |
- Ikgadējs
- Ceturkšņa
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Apgrozāmo Līdzekļu Kopsumma | 172.606 | 166.065 | 179.449 | 163.844 | 188.697 |
| Nauda un Īstermiņa Ieguldījumi | 97.659 | 103.155 | 109.775 | 78.791 | 114.657 |
| Nauda un Ekvivalenti | 97.659 | 103.155 | 109.775 | 78.791 | 114.657 |
| Debitoru Parādu Kopsumma, Neto | 41.149 | 51.117 | 48.004 | 66.486 | 53.821 |
| Accounts Receivable - Trade, Net | 41.149 | 51.117 | 48.004 | 66.486 | 53.821 |
| Total Inventory | 21.908 | 8.075 | 6.566 | 8.304 | 5.118 |
| Prepaid Expenses | 11.89 | 3.718 | 15.104 | 10.263 | 15.101 |
| Total Assets | 253.732 | 253.19 | 254.554 | 238.603 | 270.06 |
| Property/Plant/Equipment, Total - Net | 1.636 | 2.077 | 5.918 | 2.397 | 6.82 |
| Property/Plant/Equipment, Total - Gross | 7.591 | 7.268 | 10.237 | 5.744 | 9.258 |
| Accumulated Depreciation, Total | -5.955 | -5.191 | -4.319 | -3.347 | -2.438 |
| Goodwill, Net | 39.743 | 39.743 | 39.743 | 39.743 | 39.743 |
| Intangibles, Net | 10.671 | 12.917 | 15.583 | 18.103 | 23.322 |
| Other Long Term Assets, Total | 29.076 | 32.388 | 13.861 | 14.516 | 11.478 |
| Total Current Liabilities | 74.376 | 38.085 | 38.823 | 39.686 | 47.302 |
| Accounts Payable | 16.431 | 6.268 | 5.462 | 9.917 | 27.036 |
| Accrued Expenses | 32.338 | 23.817 | 28.361 | 23.519 | 15.391 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | |||||
| Total Liabilities | 77.279 | 67.179 | 75.38 | 77.841 | 90.916 |
| Total Long Term Debt | 0 | 25.135 | 33.557 | 38.155 | 42.905 |
| Other Liabilities, Total | 2.903 | 3.959 | 3 | 0 | 0.709 |
| Total Equity | 176.453 | 186.011 | 179.174 | 160.762 | 179.144 |
| Common Stock | 0.017 | 0.017 | 0.017 | 0.017 | 0.016 |
| Additional Paid-In Capital | 325.779 | 305.403 | 278.518 | 256.458 | 233.639 |
| Retained Earnings (Accumulated Deficit) | 75.862 | 84.489 | 72.5 | 58.187 | 26.284 |
| Treasury Stock - Common | -225.111 | -203.898 | -171.861 | -153.9 | -80.795 |
| Total Liabilities & Shareholders’ Equity | 253.732 | 253.19 | 254.554 | 238.603 | 270.06 |
| Total Common Shares Outstanding | 12.7914 | 13.057 | 13.6302 | 13.914 | 14.8477 |
| Current Port. of LT Debt/Capital Leases | 25.607 | 8 | 5 | 6.25 | 4.875 |
| Long Term Debt | 0 | 25.135 | 33.557 | 38.155 | 42.905 |
| Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
| Other Equity, Total | -0.094 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Apgrozāmo Līdzekļu Kopsumma | 240.166 | 172.606 | 171.694 | 175.504 | 163.986 |
| Nauda un Īstermiņa Ieguldījumi | 69.522 | 97.659 | 99.741 | 108.717 | 105.229 |
| Nauda un Ekvivalenti | 69.522 | 97.659 | 99.741 | 108.717 | 105.229 |
| Debitoru Parādu Kopsumma, Neto | 130.858 | 41.149 | 47.081 | 52.659 | 44.868 |
| Accounts Receivable - Trade, Net | 130.858 | 41.149 | 45.335 | 52.659 | 44.868 |
| Total Inventory | 24.818 | 21.908 | 9.315 | 8.294 | 6.862 |
| Prepaid Expenses | 14.968 | 11.89 | 15.557 | 5.834 | 7.027 |
| Total Assets | 320.165 | 253.732 | 256.261 | 264.242 | 259.968 |
| Property/Plant/Equipment, Total - Net | 1.627 | 1.636 | 1.775 | 1.967 | 2.27 |
| Property/Plant/Equipment, Total - Gross | 7.759 | 7.591 | 7.542 | 7.537 | 7.652 |
| Accumulated Depreciation, Total | -6.132 | -5.955 | -5.767 | -5.57 | -5.382 |
| Goodwill, Net | 39.743 | 39.743 | 39.743 | 39.743 | 39.743 |
| Intangibles, Net | 9.94 | 10.671 | 10.799 | 11.505 | 12.211 |
| Other Long Term Assets, Total | 28.689 | 29.076 | 32.25 | 35.523 | 41.758 |
| Total Current Liabilities | 101.642 | 74.376 | 48.431 | 44.664 | 41.973 |
| Accounts Payable | 14.509 | 16.431 | 12.717 | 11.136 | 12.559 |
| Accrued Expenses | 63.408 | 32.338 | 27.714 | 25.528 | 21.414 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 23.725 | 25.607 | 8 | 8 | 8 |
| Total Liabilities | 104.205 | 77.279 | 70.968 | 69.395 | 68.89 |
| Total Long Term Debt | 0 | 0 | 19.489 | 21.371 | 23.253 |
| Long Term Debt | 0 | 19.489 | 21.371 | 23.253 | |
| Other Liabilities, Total | 2.563 | 2.903 | 3.048 | 3.36 | 3.664 |
| Total Equity | 215.96 | 176.453 | 185.293 | 194.847 | 191.078 |
| Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 0.017 | 0.017 | 0.017 | 0.017 | 0.017 |
| Additional Paid-In Capital | 328.769 | 325.779 | 320.566 | 316.249 | 312.323 |
| Retained Earnings (Accumulated Deficit) | 119.92 | 75.862 | 82.058 | 87.68 | 84.068 |
| Treasury Stock - Common | -233.164 | -225.111 | -216.466 | -208.195 | -205.33 |
| Total Liabilities & Shareholders’ Equity | 320.165 | 253.732 | 256.261 | 264.242 | 259.968 |
| Total Common Shares Outstanding | 12.6971 | 12.7914 | 12.9446 | 13.0971 | 13.1455 |
| Other Equity, Total | 0.418 | -0.094 | -0.882 | -0.904 |
- Ikgadējs
- Ceturkšņa
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Neto ienākumi/Sākuma Līnija | -8.627 | 11.989 | 14.313 | 31.903 | 51.943 |
| Nauda no Darbības | 28.219 | 49.497 | 55.986 | 52.384 | 58.919 |
| Nauda no Darbības | 0.764 | 0.872 | 2.131 | 1.155 | 0.932 |
| Amortization | 2.996 | 2.666 | 2.52 | 2.515 | 2.815 |
| Deferred Taxes | -3.618 | -1.511 | 0.152 | -2.468 | 17.289 |
| Bezskaidras Naudas Preces | 27.167 | 34.665 | 22.478 | 27.168 | 15.509 |
| Cash Taxes Paid | 10.005 | 6.428 | 6.673 | 2.281 | 10.542 |
| Samaksātie Procenti Naudā | 1.197 | 2.224 | 2.478 | 2.084 | 0.651 |
| Izmaiņas Apgrozāmajā Kapitālā | 9.537 | 0.816 | 14.392 | -7.889 | -29.569 |
| Nauda no Ieguldījumu Darbībām | -5.323 | -18.247 | -0.777 | -0.133 | -5.186 |
| Kapitālie Izdevumi | -0.323 | -0.747 | -0.777 | -0.133 | -5.186 |
| Citi Ieguldījumu Naudas Plūsmas Posteņi, Kopā | -5 | -17.5 | 0 | 0 | |
| Nauda no Darbībām ar Finansēšanu | -28.392 | -37.87 | -24.225 | -88.117 | 8.104 |
| Naudas Plūsma Finansēšanas Posteņos | -1.577 | -1.525 | -0.524 | -19.877 | -1.192 |
| Akciju Izsniegšana (Atkāpšanās), Neto | -18.815 | -31.345 | -17.701 | -64.49 | -39.454 |
| Neto Izmaiņas Naudā | -5.496 | -6.62 | 30.984 | -35.866 | 61.837 |
| Parādu Izsniegšana (Atkāpšanās), Neto | -8 | -5 | -6 | -3.75 | 48.75 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 44.058 | -8.627 | -2.431 | 3.191 | -0.421 |
| Cash From Operating Activities | -16.611 | 28.219 | 20.138 | 19.071 | 10.478 |
| Cash From Operating Activities | 0.177 | 0.764 | 0.575 | 0.378 | 0.19 |
| Amortization | 0.731 | 2.996 | 2.118 | 1.412 | 0.706 |
| Deferred Taxes | -2.432 | -3.618 | -2.533 | 1.119 | 0.902 |
| Non-Cash Items | 6.616 | 27.167 | 17.689 | 10.989 | 1.378 |
| Cash Taxes Paid | 0.041 | 10.005 | 6.303 | 4.3 | 0.267 |
| Cash Interest Paid | 0.265 | 1.197 | 0.917 | 0.625 | 0.321 |
| Changes in Working Capital | -65.761 | 9.537 | 4.72 | 1.982 | 7.723 |
| Cash From Investing Activities | -0.168 | -5.323 | -5.274 | -5.269 | -5.384 |
| Capital Expenditures | -0.168 | -0.323 | -0.274 | -0.269 | -0.384 |
| Other Investing Cash Flow Items, Total | 0 | -5 | -5 | -5 | -5 |
| Cash From Financing Activities | -11.358 | -28.392 | -18.278 | -8.24 | -3.02 |
| Financing Cash Flow Items | -1.305 | -1.577 | -1.551 | -1.551 | -1.551 |
| Issuance (Retirement) of Stock, Net | -8.053 | -18.815 | -10.727 | -2.689 | 0.531 |
| Issuance (Retirement) of Debt, Net | -2 | -8 | -6 | -4 | -2 |
| Net Change in Cash | -28.137 | -5.496 | -3.414 | 5.562 | 2.074 |
| Investora vārds | Investora veids | Nenokārtots procents | Akcijas turējumā | Izmaiņas akcijās | Turēšanas termiņš | Apgrozījuma reitings |
|---|---|---|---|---|---|---|
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 12.5019 | 1635783 | 7863 | 2022-12-31 | LOW |
| Tarriff (Scott L) | Individual Investor | 12.2764 | 1606275 | 70900 | 2023-03-01 | LOW |
| Janus Henderson Investors | Investment Advisor/Hedge Fund | 9.3996 | 1229872 | -9907 | 2022-12-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 7.2761 | 952026 | -59721 | 2022-12-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 5.8236 | 761974 | -11708 | 2022-12-31 | LOW |
| Brandes Investment Partners, L.P. | Investment Advisor | 3.1807 | 416177 | -51680 | 2022-12-31 | LOW |
| Adage Capital Management, L.P. | Hedge Fund | 3.0571 | 400000 | 150000 | 2022-12-31 | LOW |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 2.672 | 349606 | -6153 | 2022-12-31 | LOW |
| Renaissance Technologies LLC | Hedge Fund | 2.0379 | 266650 | -7629 | 2022-12-31 | HIGH |
| Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 1.77 | 231587 | -79633 | 2022-12-31 | MED |
| Smith, Graham & Co. Investment Advisors, L.P. | Investment Advisor | 1.7672 | 231222 | -799 | 2022-12-31 | LOW |
| Quoniam Asset Management GmbH | Investment Advisor/Hedge Fund | 1.7569 | 229871 | -55740 | 2022-12-31 | MED |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.5309 | 200305 | 3708 | 2022-12-31 | LOW |
| Charles Schwab Investment Management, Inc. | Investment Advisor | 1.2452 | 162931 | 19807 | 2022-12-31 | LOW |
| Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 1.2246 | 160236 | -2596 | 2022-12-31 | LOW |
| LSV Asset Management | Investment Advisor | 1.1573 | 151418 | 126068 | 2022-12-31 | LOW |
| Allspring Global Investments, LLC | Investment Advisor/Hedge Fund | 1.1512 | 150628 | 62456 | 2022-12-31 | LOW |
| Scout Investments, Inc. | Investment Advisor | 1.0749 | 140642 | -2342 | 2022-12-31 | MED |
| AQR Capital Management, LLC | Investment Advisor/Hedge Fund | 1.0342 | 135315 | 39400 | 2022-12-31 | LOW |
| Morgan Stanley & Co. LLC | Research Firm | 1.0278 | 134477 | -15478 | 2022-12-31 | MED |
Kāpēc izvēlēties Capital.com? Mūsu skaitļi runā paši par sevi.
Capital.com Group500K+
Tirgotāji
92K+
Ikmēneša aktīvie klienti
$53M+
Ikmēneša ieguldījumu apjoms
$30M+
Izņemts katru mēnesi
Treidinga kalkulators
Aprēķiniet iespējamo peļņu un zaudējumus, uzsākot CFD darījumu noteiktā dienā (izvēlaties datumu) un slēdzot darījumu citā dienā (izvēlaties datumu).
Tirdzniecības komisija
0
- 1:1
Finanšu svira
1:1
- 20
- 100
- 500
- 1000
- 10000
Investīcija
Darījuma apjoms (Kredītplecs x Investīcija):
Atvēršana
Aizvēršana
Īss Garšs
Eagle Pharm Company profile
Par Eagle Pharm
Eagle Pharmaceuticals, Inc. ir integrēts farmācijas uzņēmums. Uzņēmums veic molekulas izstrādi no pirmsklīniskajiem pētījumiem līdz regulatīvajam apstiprinājumam un laišanai tirgū, ieskaitot izstrādi, ražošanu un komercializāciju. Uzņēmums identificē grūti ārstējamas centrālās nervu sistēmas vai vielmaiņas kritiskās aprūpes terapeitiskās jomas, kā arī onkoloģijas jomas. Uzņēmums piedāvā trīs produktus: Ryanodex, dantrolēna nātrija sāls) (Ryanodex), bendamustīns, kas gatavs atšķaidīšanai (RTD) 500 ml šķīdumā (Belrapzo), un ātri infundējams bendamustīns RTD (Bendeka). Uzņēmums tirgo Ryanodex un Belrapzo un Teva Pharmaceutical Industries Ltd. (Teva) Japānā tirgo bendamustīna hidrohlorīda liofilizētu pulvera formu Bendeka.
| Industry: | Proprietary & Advanced Pharmaceuticals |
50 Tice Boulevard, Suite 315
WOODCLIFF LAKE
NEW JERSEY 07677
US
Peļņas Atskaite
- Annual
- Quarterly
Cilvēki arī skatās
Vai joprojām meklējat mākleri, kuram varat uzticēties?
Pievienojieties 500 000+ tirgotājiem visā pasaulē, kuri izvēlējās tirgoties ar Capital.com